Savara receives UK regulatory acceptance for rare lung disease drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. META
5. SPY
6. ACN
7. IBM
8. PRIM
9. PFE
10. TSLA

Go back to Savara receives UK regulatory acceptance for rare lung disease drug
(NASDAQ: SVRA) Delayed: 5.88 +0.19 (3.34%)
Previous Close $5.69    52 Week High $ 
Open $5.64    52 Week Low $ 
Day High $5.90    P/E N/A 
Day Low $5.60    EPS $ 
Volume 890,225